| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/10/2000 | CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/09/2000 | EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression |
| 02/09/2000 | EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments |
| 02/09/2000 | EP0977893A1 Reagents and methods useful for detecting diseases of the prostate |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977753A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | EP0977562A1 Methods and compositions for delivery of taxanes |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | CN1049214C Phenylimidazolidines, process for their preparation, their use as medicament and pharmaceutical compositions containing them. |
| 02/09/2000 | CN1049116C Process for treating cardiovascular hypertrophy and hyperplasia |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022971 Azetidines |
| 02/08/2000 | US6022899 Effective inhibitors of the cellular sodium proton antiporter |
| 02/08/2000 | US6022886 Endothelin receptor antagonists |
| 02/03/2000 | WO2000005260A1 Peptide analogues of pacap |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000005206A1 Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004886A1 Formulations for the transdermal administration of fenoldopam |
| 02/03/2000 | WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | WO2000004862A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 02/03/2000 | WO1999065922A3 Prenyl transferase inhibitors |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 02/03/2000 | DE19834045A1 (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin (4-amino-5-ethylpyrimidine-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | CA2335341A1 Peptide analogues of pacap |
| 02/02/2000 | EP0976400A1 Preventive or remedy for kidney diseases |
| 02/02/2000 | EP0976398A2 Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| 02/02/2000 | EP0975963A1 Prostate specific antigen substrates |
| 02/02/2000 | EP0975769A1 Novel prostate-associated kallikrein |
| 02/02/2000 | EP0975631A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands |
| 02/02/2000 | EP0975629A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators |
| 02/02/2000 | EP0975623A2 Indazole amide compounds as serotoninergic agents |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975349A1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 02/02/2000 | EP0975344A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo |
| 02/02/2000 | EP0881891A4 Male contraceptive implant |
| 02/02/2000 | EP0767794B1 Phosphinic acid derivatives |
| 02/02/2000 | CN1243513A Quinoline and quinozoline compounds useful in therapy, particularly in the theatment of begnin prostatic hyperplasia |
| 02/02/2000 | CN1242995A Enema for rescuring patient suffering from renal syndrome-hemorrhagic fever renal faiture |
| 02/01/2000 | US6020513 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
| 02/01/2000 | US6020348 Endothelin receptor antagonists |
| 02/01/2000 | US6020314 Methods for treatment of neurological disorders |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020172 Nucleic acid delivery with ovine adenoviral vectors |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 01/27/2000 | WO2000004027A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | WO2000004012A1 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000003704A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | DE19828114A1 Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV Prodrugs unstable inhibitors of dipeptidyl peptidase IV |
| 01/27/2000 | CA2338122A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2338037A1 Compounds specific for the human .alpha.1d adrenergic receptor and uses thereof |
| 01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | CA2336950A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
| 01/26/2000 | EP0973774A1 1,5-dihydro-pyrazolo 3,4-d]-pyrimidinone derivatives |
| 01/26/2000 | EP0973769A1 Process for preparing eprosartan |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 01/26/2000 | EP0650484B1 Endothelin receptor antagonists |
| 01/26/2000 | CN1242234A Method for preparing traditional Chinese medicine for calculuse diseases |
| 01/25/2000 | US6017964 Administering to a male patient droloxifene or it's derivatives know as an antiestrogenic agent |
| 01/25/2000 | US6017945 Useful in the treatment of restenosis, renal failure and pulmonary hypertension |
| 01/25/2000 | US6017942 A peritoneal dialysis solution comprising a therapeutically effective amount of l-carnosine |
| 01/25/2000 | US6017927 Quinuclidine derivatives and medicinal composition thereof |
| 01/25/2000 | US6017908 3-EPI vitamin D2 compounds and uses thereof |
| 01/25/2000 | US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma |
| 01/25/2000 | CA2163904C Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 01/20/2000 | WO2000002865A1 Pharmaceutical agents |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | WO1999055347A3 Treatment of papilloma virus infection using a mycobacterium |
| 01/20/2000 | WO1999048858A3 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 01/20/2000 | CA2337795A1 Pharmaceutical agents |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |